Background. Eight randomized controlled trials (RCTs) of screening mammography were
conducted involving women ages 40 to 49 years at entry. Current data gathered for periods …

Eight randomized controlled trials (RCTs) of screening mammography have been conducted
involving women aged 40-49 at entry. Current data are now available from these trials at …

In randomized controlled trials, screening mammography has been shown to reduce
mortality from breast cancer about 25% to 30% among women aged 50 to 69 years after …

Objective: A previous review by the Canadian Task Force on the Periodic Health
Examination (now the Canadian Task Force on Preventive Health Care) in 1994 indicated …

In the hope of resolving underlying policy questions related to the value of breast cancer
screening with mammography for women younger than 50 years of age, the National …

We reviewed the evidence relating to breast screening using mammography in younger
women, primarily those aged 40 to 49. The best evidence comes from the 6 published …

Background: The risks and benefits of mammography screening among women 40 to 49
years of age remain an important issue for clinical practice. Purpose: To evaluate the …

Objective.—To determine the efficacy of screening mammography by age, number of
mammographic views per screen, screening interval, and duration of follow-up. Design …

Objective Although there is clear evidence from randomised trials of the effectiveness of
mammographic screening in women over 50 in reducing mortality from breast cancer, the …

Background The efficacy of screening by mammography has been shown in randomised
controlled trials in women aged 50 years and older, but is less clear in younger women. A …